The United Laboratories Stock Debt To Equity
| ULIHFDelisted Stock | USD 1.09 0.00 0.00% |
The United Laboratories fundamentals help investors to digest information that contributes to United Laboratories' financial success or failures. It also enables traders to predict the movement of United Pink Sheet. The fundamental analysis module provides a way to measure United Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to United Laboratories pink sheet.
United |
The United Laboratories Company Debt To Equity Analysis
United Laboratories' Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current United Laboratories Debt To Equity | 0.22 % |
Most of United Laboratories' fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, The United Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
CompetitionAccording to the company disclosure, The United Laboratories has a Debt To Equity of 0.22%. This is 99.59% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The debt to equity for all United States stocks is 99.55% higher than that of the company.
United Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses United Laboratories' direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of United Laboratories could also be used in its relative valuation, which is a method of valuing United Laboratories by comparing valuation metrics of similar companies.United Laboratories is currently under evaluation in debt to equity category among its peers.
United Fundamentals
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0539 | |||
| Profit Margin | 0.1 % | |||
| Operating Margin | 0.14 % | |||
| Current Valuation | 850.36 M | |||
| Shares Outstanding | 1.82 B | |||
| Shares Owned By Insiders | 50.35 % | |||
| Shares Owned By Institutions | 8.56 % | |||
| Price To Earning | 8.47 X | |||
| Price To Book | 0.67 X | |||
| Price To Sales | 0.11 X | |||
| Revenue | 9.7 B | |||
| Gross Profit | 4.21 B | |||
| EBITDA | 1.26 B | |||
| Net Income | 988.1 M | |||
| Cash And Equivalents | 4.04 B | |||
| Cash Per Share | 2.22 X | |||
| Total Debt | 221.21 M | |||
| Debt To Equity | 0.22 % | |||
| Current Ratio | 1.60 X | |||
| Book Value Per Share | 5.36 X | |||
| Cash Flow From Operations | 1.54 B | |||
| Earnings Per Share | 0.08 X | |||
| Number Of Employees | 13.6 K | |||
| Beta | 0.3 | |||
| Market Capitalization | 1.29 B | |||
| Total Asset | 16.33 B | |||
| Z Score | 3.0 | |||
| Annual Yield | 0.03 % | |||
| Net Asset | 16.33 B | |||
| Last Dividend Paid | 0.13 |
About United Laboratories Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze The United Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of United Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of The United Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in United Pink Sheet
If you are still planning to invest in The United Laboratories check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the United Laboratories' history and understand the potential risks before investing.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |